TRV GP IV, LLC — Q1 2026 13F-HR

← TRV GP IV, LLC

Q1 2026 · 13F-HR

TRV GP IV, LLCholdings as filed

Filed 2026-05-07 · accession 0001193125-26-212011

$266.9M

Reported value

Positions

2026-03-31

Period end

View analyzed profile →PRO

The Brief · TRV GP IV, LLC · Q1 2026

AI · grounded in 13F

TRV GP IV, LLC reduced its position in Tango Therapeutics, Inc. TNGX by 19.05%. The fund added no new positions during the period. Total assets under management stood at $266.9M across two holdings.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
578784100	MAZE	MAZE THERAPEUTICS, INC.	$133.5M	50.0%	4,473,958	Common	SOLE
87583X109	TNGX	TANGO THERAPEUTICS, INC.	$133.4M	50.0%	6,374,574	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.